OpenEvidence’s Meteoric Rise Is Huge For Doctors

OpenEvidence has raised hundreds of millions of dollars. In its most recent funding round, it raised a $210 million Series B from prominent investors such as Google Ventures and Kleiner Perkins, bringing the company’s valuation to nearly $3.5 billion.

The company’s goal is straightforward and incredibly ambitious: to collate the entire corpus of medical knowledge and research developments in a way that is easily…